📣 It’s happening. The first patient in our case studies got his pre-treatment blood work done this week!      We sent a mobile phlebotomist to his home to collect the sample, saving him the trip to the lab.  We know how difficult it can be for very severe home- and bedbound patients to make it to a medical facility.   So we designed our protocol to be as easy for patients as possible. Patient #1’s blood will be sent off to our laboratory facility in southern California.  We’ll be running several tests on it - including transcriptomics, a cutting-edge technique that we believe holds huge potential for detecting persistence of the SARS-Cov-2 virus. 🦠 The persistence of the SARS-Cov-2 virus is what we believe to be the leading hypothesis for the root cause of Long COVID.  Treating this chronic infection is what cured our founder @rd108, and we believe this could be the answer for so many suffering. ❤️‍🩹 The transcriptomics test will allow us to quantify SARS-Cov-2 RNA and the associated inflammatory gene signatures in blood.  This means we’re measuring both signs of the virus itself, as well as changes in the patient’s immune response that would show the virus is still there.   We’ll be measuring these markers before and after treatment, and we expect the abnormal markers will begin to return to normal, if the treatment is successful! ✨ We’ll also be running additional labs, both for the purposes of safety monitoring, as well as to see if we can validate some of the existing research that’s been done on Long COVID biomarkers.  (More info on that to come!). Our team is incredibly excited to finally get these biomarker tests up and running!   Patient #1 will be receiving his treatment next week. We can’t wait to see where things go!  ✨🙏 🌍